Human illnesses caused by Salmonella has been an issue that the Centers for Disease Control and Prevention (CDC) and USDA’s FSIS have been grappling with for many years.
Researchers build a quantitative microbial risk assessment of Salmonella in poultry products to assess the likely impact on foodborne disease of interventions, performance standards and regulations targeting Salmonella levels and/or specific serotypes.
bioMérieux enters into a strategic research collaboration with the FDA, Center for Food Safety and Applied Nutrition, Offices of Applied Research and Safety Assessment and Regulatory Science to develop tools to combat foodborne pathogens.